Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 55, Issue 36, Pages 10676-10680
Publisher
Wiley
Online
2016-08-03
DOI
10.1002/anie.201604858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
- (2016) Yonghyun Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanoparticle-Loaded Protein-Polymer Nanodroplets for Improved Stability and Conversion Efficiency in Ultrasound Imaging and Drug Delivery
- (2015) Jeong Yu Lee et al. ADVANCED MATERIALS
- A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance
- (2015) Ming-Fan Chung et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Reactive Oxygen Species-Responsive Protein Modification and Its Intracellular Delivery for Targeted Cancer Therapy
- (2014) Ming Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Biliverdin’s regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer
- (2014) J Zheng et al. BRITISH JOURNAL OF CANCER
- Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
- (2014) Vladimir P. Torchilin NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Angiogenesis by Antioxidant Micelles
- (2014) Masaki Moriyama et al. Advanced Healthcare Materials
- pH-Responsive Micro- and Nanocarrier Systems
- (2013) Sabrina Nowag et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Reactive Oxygen Species (ROS)-Responsive Polymer for Safe, Efficient, and Targeted Gene Delivery in Cancer Cells
- (2013) Min Suk Shim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis
- (2013) Seung Joo Kang et al. ATHEROSCLEROSIS
- The molecular basis for the immunomodulatory activities of unconjugated bilirubin
- (2013) Sushrut Jangi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Novel Nanoparticles Generated by Polymeric Amphiphiles with π–π Conjugated Small Molecules for Anti-Tumor Drug Delivery
- (2013) Xin Deng et al. Journal of Biomedical Nanotechnology
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
- (2013) Shailendra Giri et al. PLoS One
- Photocontrolled Targeted Drug Delivery: Photocaged Biologically Active Folic Acid as a Light-Responsive Tumor-Targeting Molecule
- (2012) Nien-Chu Fan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- DNA Self-Assembly of Targeted Near-Infrared-Responsive Gold Nanoparticles for Cancer Thermo-Chemotherapy
- (2012) Zeyu Xiao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ultrasensitive detection of toxic cations through changes in the tunnelling current across films of striped nanoparticles
- (2012) Eun Seon Cho et al. NATURE MATERIALS
- Serum Bilirubin and Risk of Respiratory Disease and Death
- (2011) Laura J. Horsfall JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin Reductase
- (2009) Ghassan J. Maghzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bilirubin and glutathione have complementary antioxidant and cytoprotective roles
- (2009) T. W. Sedlak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phototherapy for Neonatal Jaundice
- (2008) M. Jeffrey Maisels et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started